3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 3, Active not recruiting 1, Enrolling by invitation 1, Terminated 1, Unknown 1 |
Follow Granuloma: new trials by email Literature Review of Granuloma trials Research Report on Granuloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA Mepolizumab 100 MG Injection [Nucala], Mepolizumab 300 mg - EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma | Phase 4 | Enrolling by invitation | Azienda Ospedaliero Universitaria di Cagliari | 90 | 2025-10-17 | 2026-01-15 |
| Crizotinib Continuation Clinical Study crizotinib - NSCLC, ALCL | Phase 4 | Active not recruiting | Pfizer | 27 | 2021-12-27 | 2026-03-30 |
| Hydroxychloroquine in ANCA Vasculitis Evaluation Hydroxychloroquine, Placebo - ANCA Associated Vasculitis, Microscopic Polyangiitis | Phase 4 | Terminated | Guy's and St Thomas' NHS Foundation Trust | 43 | 2020-12-17 | 2026-04-29 |
| Pain Outcomes Following Intralesional Corticosteroid Injections Corticosteroid with lidocaine, Corticosteroid with normal saline - Keloid, Alopecia Areata | Phase 4 | Completed | Vanderbilt University Medical Center | 31 | 2018-10-01 | 2021-03-11 |
| Treatment of Tracheostomy Granulomas Betadine, Silver Nitrate, Hydrocortisone Butyrate Cream, 1.0% - Granuloma, Tracheostomy | Phase 4 | Completed | University of Colorado, Denver | 26 | 2014-09-01 | 2021-09-13 |
| Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years prednisone, methylprednisolone,cyclophosphamides, Cyclophosphamide, Azathioprine,prednisone,methylprednisolone, Mycophenolate mofetil,methotrexate - Vasculitis, Wegener's Granulomatosis | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 108 | 2005-07-01 | 2011-09-12 |
| CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors azathioprine, cyclophosphamide - Churg-Strauss Syndrome | Phase 4 | Unknown | Hospices Civils de Lyon | 72 | 1996-07-01 | 2006-11-14 |
Churg-Strauss Syndrome (4) · Granulomatosis with Polyangiitis (2) · Microscopic Polyangiitis (2) · Vasculitis (2) · Acne Vulgaris (1) · Alopecia Areata (1) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Asthma (1) · Carcinoma, Non-Small-Cell Lung (1) · Cicatrix, Hypertrophic (1) · Dermoid Cyst (1) · Granuloma Annulare (1) · Granuloma, Plasma Cell (1) · Keloid (1)
Hemic and Lymphatic Diseases (6) · Lymphatic Diseases (6) · Lymphoproliferative Disorders (6) · Immune System Diseases (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Autoimmune Diseases (4) · Cardiovascular Diseases (4) · Lung Diseases (4) · Respiratory Tract Diseases (4) · Skin Diseases, Vascular (4) · Systemic Vasculitis (4) · Vascular Diseases (4) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3)
Azathioprine (2) · Cyclophosphamide (2) · Adrenal Cortex Hormones (1) · Crizotinib (1) · Hydroxychloroquine (1) · Injections (1) · Lidocaine (1) · Methotrexate (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Povidone-Iodine (1) · Prednisone (1) · Saline Solution (1) · Silver Nitrate (1) · mepolizumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Azienda Ospedaliero Universitaria di Cagliari (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Hospices Civils de Lyon (1) · Pfizer (1) · University of Colorado, Denver (1) · Vanderbilt University Medical Center (1)
Italy (2) · United States (2) · China (1) · France (1) · Japan (1) · Russia (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1)
Brian Drolet, MD (1) · David D'Cruz (1) · Jeremy Prager, MD (1)
PMID 18240234, PMID 23590801, PMID 25153486, PMID 25693055, PMID 33760691, PMID 37024906
2018 (1)